DAP3 (P51398) variants and mutations
DAP3 (also known as P51398) is a human protein-coding gene encoding a small ribosomal subunit protein mS29 protein. It forms part of the small mitochondrial ribosomal subunit, supporting synthesis of proteins encoded by mitochondrial DNA, and also participates in cell-death signaling. Biallelic pathogenic variants can cause Perrault syndrome 7, with sensorineural hearing loss and ovarian dysfunction in affected females, sometimes accompanied by neurological features. This analysis covers 651 DAP3 variants and mutations. Of these, 97% have computational variant effect predictions. Disease context includes Perrault syndrome 7, neurodegenerative disease, and grange syndrome. Example DAP3 variants include M2I, M2V, and M2L.
Variant analysis overview
- Gene: DAP3
- Protein: P51398
- UniProt accession: P51398
- Organism: Homo sapiens
- Variants analyzed: 651
- Variant scope: all variants
- Completed: 2026-10-10
Variant and mutation evidence
- Variant composition: 500 unspecified-consequence records; 92 missense variants; 54 synonymous variants; 5 stop-gained variants; 3 splice-region variants; 8 frameshift variants; 1 in-frame deletions; 1 in-frame insertions; 1 substitution
- Prediction scores: 634 variants have prediction scores (97% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Perrault syndrome 7, neurodegenerative disease, grange syndrome, Perrault syndrome 1, prostate carcinoma, psoriasis, idiopathic pulmonary fibrosis, atrial fibrillation, hereditary disease, neoplasm, hepatocellular carcinoma, cancer.
Protein structure and variant hotspots
- Protein features: 2 binding sites; 2 post-translational modification sites.
- PTM context: 6 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Diseases linked to DAP3
Notable DAP3 variants
Examples include M2I, M2V, M2L, L3L, G5E, G5R, G5V, G5*. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M2I (p.Met2Ile), ESP rs372811843, TOPMed rs372811843, gnomAD rs372811843, REVEL 0.14, ESM-1b 0.00
- M2V (p.Met2Val), TOPMed rs1656467491, ESM-1b 0.00, AlphaMissense 0.16
- M2L (p.Met2Leu), gnomAD 1-155709783-A-T, REVEL 0.15, ESM-1b 0.00
- L3L (p.Leu3Leu), gnomAD 1-155709788-G-T, CADD 13.20
- G5E (p.Gly5Glu), 1000Genomes rs61755343, ESP rs61755343, ExAC rs61755343, TOPMed rs61755343, REVEL 0.02, ESM-1b 0.00
- G5R (p.Gly5Arg), cosmic curated COSV58023, Ensembl rs1410395608, REVEL 0.04, ESM-1b 0.00
- G5V (p.Gly5Val), 1000Genomes rs61755343, ESP rs61755343, ExAC rs61755343, TOPMed rs61755343, REVEL 0.03, ESM-1b 0.00
- G5* (p.Gly5Ter), gnomAD 1-155709792-G-T, CADD 35.00
- G5G (p.Gly5Gly), rs762850317, gnomAD 1-155709794-A-G, CADD 14.30
- I6V (p.Ile6Val), gnomAD 1-155709795-A-G, REVEL 0.08, ESM-1b 0.00
- T7I (p.Thr7Ile), ExAC rs772166563, ESM-1b 0.00, AlphaMissense 0.12
- T7K (p.Thr7Lys), gnomAD 1-155709799-C-A, REVEL 0.07, ESM-1b 0.00
- T7R (p.Thr7Arg), gnomAD 1-155709799-C-G, REVEL 0.04, ESM-1b 0.00
- R8G (p.Arg8Gly), gnomAD rs1432674029, ESM-1b 0.00, AlphaMissense 0.07
- R8K (p.Arg8Lys), TOPMed rs1656470494, REVEL 0.02, ESM-1b 0.00
- R8M (p.Arg8Met), gnomAD 1-155709802-G-T, REVEL 0.09, ESM-1b 0.05
- R8S (p.Arg8Ser), gnomAD 1-155709803-G-T, REVEL 0.07, ESM-1b 0.00
- L9V (p.Leu9Val), TOPMed rs1656470831, gnomAD rs1656470831, REVEL 0.02, ESM-1b 0.00
- L9L (p.Leu9Leu), gnomAD 1-155709806-T-C, CADD 5.17
- I10L (p.Ile10Leu), ExAC rs775495982, gnomAD rs775495982, REVEL 0.07, ESM-1b 0.00
- I10V (p.Ile10Val), gnomAD 1-155709807-A-G, REVEL 0.08, ESM-1b 0.00
- S11C (p.Ser11Cys), gnomAD 1-155709811-C-G, REVEL 0.05, ESM-1b 0.00
- R12K (p.Arg12Lys), ExAC rs760898731, TOPMed rs760898731, gnomAD rs760898731, REVEL 0.03, ESM-1b 0.00
- R12S (p.Arg12Ser), gnomAD 1-155709815-G-C, REVEL 0.03, ESM-1b 0.00
- R12R (p.Arg12Arg), rs1656471809, gnomAD 1-155709815-G-A, CADD 12.10
- I13N (p.Ile13Asn), TOPMed rs1470221997, gnomAD rs1470221997, REVEL 0.10, ESM-1b 0.00
- I13I (p.Ile13Ile), rs1169838204, gnomAD 1-155709818-C-A, CADD 10.00
- H14D (p.His14Asp), gnomAD rs1397911722, REVEL 0.02, ESM-1b 0.00
- H14R (p.His14Arg), rs764152940, ClinGen CA1149142, ClinVar RCV004370897, ExAC rs764152940, REVEL 0.04, ESM-1b 0.00, Uncertain significance, not specified
- H14Y (p.His14Tyr), gnomAD rs1397911722, REVEL 0.04, ESM-1b 0.00
- H14L (p.His14Leu), gnomAD 1-155709820-A-T, REVEL 0.03, ESM-1b 0.00
- H14H (p.His14His), rs1298460422, gnomAD 1-155709821-T-C, CADD 4.54
- K15R (p.Lys15Arg), gnomAD 1-155709823-A-G, REVEL 0.02, ESM-1b 0.00
- K15K (p.Lys15Lys), rs1287047821, gnomAD 1-155709824-G-A, CADD 25.80
- D17V (p.Asp17Val), gnomAD rs1345656156, REVEL 0.06, ESM-1b 0.00
- D17D (p.Asp17Asp), rs377463084, gnomAD 1-155717011-C-T, CADD 3.15
- P18L (p.Pro18Leu), TOPMed rs1278123325, gnomAD rs1278123325, REVEL 0.05, ESM-1b 0.00, Uncertain significance, not specified
- P18W (p.Pro18Trp), gnomAD 1-155717010-ACC-A, CADD 22.60
- P18S (p.Pro18Ser), gnomAD 1-155717012-C-T, REVEL 0.04, ESM-1b 0.00
- G19R (p.Gly19Arg), TOPMed rs1657416568, ESM-1b 0.00, AlphaMissense 0.08
- G19V (p.Gly19Val), gnomAD 1-155717016-G-T, REVEL 0.15, ESM-1b 0.00
- G19A (p.Gly19Ala), gnomAD 1-155717016-G-C, REVEL 0.12, ESM-1b 0.00
- G19G (p.Gly19Gly), rs1339014620, gnomAD 1-155717017-G-A, CADD 1.41
- R20C (p.Arg20Cys), rs770793096, ClinGen CA1149159, cosmic curated COSV58022, ClinVar RCV004110137, REVEL 0.01, ESM-1b 0.65, Uncertain significance, not provided; not specified
- R20H (p.Arg20His), rs1274099843, NCI-TCGA Cosmic COSV5802, cosmic curated COSV58020, TOPMed rs1274099843, REVEL 0.01, ESM-1b 0.38, Variant assessed as somatic; moderate impact.
- R20S (p.Arg20Ser), cosmic curated COSV58019, ESM-1b 0.13, AlphaMissense 0.14
- R20L (p.Arg20Leu), gnomAD 1-155717019-G-T, REVEL 0.01, ESM-1b 0.72
- F21V (p.Phe21Val), Ensembl rs2149164695, ESM-1b 0.00, AlphaMissense 0.07
- F21S (p.Phe21Ser), gnomAD 1-155717022-T-C, REVEL 0.05, ESM-1b 0.00
- L22L (p.Leu22Leu), gnomAD 1-155717024-T-C, CADD 3.96
- L22F (p.Leu22Phe), gnomAD 1-155717026-A-C, REVEL 0.06, ESM-1b 0.00
- H23P (p.His23Pro), 1000Genomes rs560216710, TOPMed rs560216710, REVEL 0.07, ESM-1b 0.08
- H23R (p.His23Arg), 1000Genomes rs560216710, TOPMed rs560216710, REVEL 0.09, ESM-1b 0.00
- H23N (p.His23Asn), gnomAD 1-155717027-C-A, REVEL 0.09, ESM-1b 0.00
- H23Y (p.His23Tyr), gnomAD 1-155717027-C-T, REVEL 0.10, ESM-1b 0.00
- H23H (p.His23His), rs1657419295, gnomAD 1-155717029-C-T, CADD 0.74
- M24L (p.Met24Leu), TOPMed rs1557781464, ESM-1b 0.00, AlphaMissense 0.08
- M24T (p.Met24Thr), ExAC rs775549205, gnomAD rs775549205, REVEL 0.02, ESM-1b 0.00, Uncertain significance, not specified
- M24V (p.Met24Val), TOPMed rs1557781464, REVEL 0.01, ESM-1b 0.00
- M24R (p.Met24Arg), gnomAD 1-155717030-ATG-A, CADD 22.50
- M24K (p.Met24Lys), gnomAD 1-155717031-T-A, REVEL 0.02, ESM-1b 0.00
- M24I (p.Met24Ile), gnomAD 1-155717032-G-C, REVEL 0.02, ESM-1b 0.00
- G25W (p.Gly25Trp), gnomAD 1-155717033-G-T, REVEL 0.11, ESM-1b 0.00
- G25E (p.Gly25Glu), gnomAD 1-155717034-G-A, REVEL 0.05, ESM-1b 0.00
- G25V (p.Gly25Val), gnomAD 1-155717034-G-T, REVEL 0.04, ESM-1b 0.00
- G25G (p.Gly25Gly), rs145834196, gnomAD 1-155717035-G-T, CADD 1.70
- T26I (p.Thr26Ile), Ensembl rs1571507494, REVEL 0.03, ESM-1b 0.00
- T26S (p.Thr26Ser), Ensembl rs1333441738, REVEL 0.03, ESM-1b 0.00
- T26T (p.Thr26Thr), rs768765455, gnomAD 1-155717038-C-G, CADD 3.37
- Q27* (p.Gln27Ter), gnomAD rs1490553650
- Q27E (p.Gln27Glu), gnomAD 1-155717039-C-G, REVEL 0.04, ESM-1b 0.00
- Q27P (p.Gln27Pro), gnomAD 1-155717040-A-C, REVEL 0.04, ESM-1b 0.00
- A28A (p.Ala28Ala), gnomAD 1-155717044-T-A, CADD 4.64
- R29C (p.Arg29Cys), cosmic curated COSV10519, 1000Genomes rs145929335, ESP rs145929335, ExAC rs145929335, REVEL 0.01, ESM-1b 0.00
- R29H (p.Arg29His), ESP rs369774038, ExAC rs369774038, TOPMed rs369774038, gnomAD rs369774038, REVEL 0.04, ESM-1b 0.00
- R29L (p.Arg29Leu), gnomAD 1-155717046-G-T, REVEL 0.03, ESM-1b 0.00
- R29R (p.Arg29Arg), rs1187003407, gnomAD 1-155717047-C-T, CADD 2.22
- Q30Q (p.Gln30Gln), gnomAD 1-155717050-A-G, CADD 4.41
- S31G (p.Ser31Gly), ESP rs370992701, ExAC rs370992701, gnomAD rs370992701, REVEL 0.06, ESM-1b 0.00
- S31R (p.Ser31Arg), rs1657423105, gnomAD 1-155717053-C-G, REVEL 0.02, ESM-1b 0.00
- I32L (p.Ile32Leu), ESP rs200523835, ExAC rs200523835, TOPMed rs200523835, gnomAD rs200523835, REVEL 0.04, ESM-1b 0.00, Likely benign, not specified
- I32S (p.Ile32Ser), ExAC rs763561074, gnomAD rs763561074, REVEL 0.05, ESM-1b 0.00
- I32V (p.Ile32Val), ESP rs200523835, ExAC rs200523835, TOPMed rs200523835, gnomAD rs200523835, REVEL 0.03, ESM-1b 0.00, Likely benign
- I32M (p.Ile32Met), gnomAD 1-155717054-ATTGC, CADD 23.00
- I32I (p.Ile32Ile), gnomAD 1-155717056-T-C, CADD 9.44
- A33A (p.Ala33Ala), gnomAD 1-155717059-T-A, CADD 8.12
- A34V (p.Ala34Val), rs1019811247, gnomAD 1-155717061-C-T, REVEL 0.03, ESM-1b 0.00
- H35R (p.His35Arg), TOPMed rs1418571902, gnomAD rs1418571902, REVEL 0.01, ESM-1b 0.00, Uncertain significance, not specified
- H35Y (p.His35Tyr), rs1365737302, NCI-TCGA Cosmic COSV5802, cosmic curated COSV58023, gnomAD rs1365737302, REVEL 0.06, ESM-1b 0.00, Variant assessed as somatic; moderate impact.
- H35D (p.His35Asp), gnomAD 1-155717063-C-G, REVEL 0.02, ESM-1b 0.00
- L36R (p.Leu36Arg), gnomAD rs1295753368, REVEL 0.08, ESM-1b 0.00
- L36L (p.Leu36Leu), gnomAD 1-155717066-C-T, CADD 8.28
- D37H (p.Asp37His), TOPMed rs1657425674, ESM-1b 0.00, AlphaMissense 0.11
- D37G (p.Asp37Gly), gnomAD 1-155717070-A-G, REVEL 0.03, ESM-1b 0.00
- N38K (p.Asn38Lys), ExAC rs752102492, gnomAD rs752102492, REVEL 0.03, ESM-1b 0.00
- N38D (p.Asn38Asp), gnomAD 1-155717072-A-G, REVEL 0.03, ESM-1b 0.00
- N38S (p.Asn38Ser), gnomAD 1-155717073-A-G, REVEL 0.05, ESM-1b 0.00
- Q39* (p.Gln39Ter), ExAC rs755677116, TOPMed rs755677116, gnomAD rs755677116, CADD 36.00
- Q39E (p.Gln39Glu), ExAC rs755677116, TOPMed rs755677116, gnomAD rs755677116, REVEL 0.08, ESM-1b 0.00
- Q39H (p.Gln39His), rs752327968, NCI-TCGA Cosmic COSV5802, cosmic curated COSV58022, ExAC rs752327968, REVEL 0.08, ESM-1b 0.00, Variant assessed as somatic; moderate impact.
- Q39K (p.Gln39Lys), ExAC rs755677116, TOPMed rs755677116, gnomAD rs755677116, ESM-1b 0.00, AlphaMissense 0.07
- Q39R (p.Gln39Arg), rs146211768, ClinGen CA1149172, ClinVar RCV004370896, ESP rs146211768, REVEL 0.06, ESM-1b 0.00, Uncertain significance, not specified
- V40F (p.Val40Phe), TOPMed rs925547082, REVEL 0.04, ESM-1b 0.00
- V40I (p.Val40Ile), cosmic curated COSV10817, ESM-1b 0.00, AlphaMissense 0.07
- P41A (p.Pro41Ala), gnomAD rs1317435523, REVEL 0.07, ESM-1b 0.00
- P41P (p.Pro41Pro), gnomAD 1-155717083-A-T, CADD 10.50
- V42A (p.Val42Ala), ExAC rs755738906, gnomAD rs755738906, REVEL 0.03, ESM-1b 0.00
- V42D (p.Val42Asp), ExAC rs755738906, gnomAD rs755738906, REVEL 0.02, ESM-1b 0.00
- V42L (p.Val42Leu), gnomAD 1-155717084-G-C, REVEL 0.02, ESM-1b 0.00
- V42V (p.Val42Val), gnomAD 1-155717086-T-G, CADD 5.71
- E43K (p.Glu43Lys), ExAC rs749012692, TOPMed rs749012692, gnomAD rs749012692, REVEL 0.12, ESM-1b 0.00
- E43G (p.Glu43Gly), gnomAD 1-155717088-A-G, REVEL 0.04, ESM-1b 0.00
- E43E (p.Glu43Glu), gnomAD 1-155717089-G-A, CADD 6.33
- S44R (p.Ser44Arg), ExAC rs757038621, gnomAD rs757038621, REVEL 0.06, ESM-1b 0.00
- S44T (p.Ser44Thr), gnomAD 1-155717091-G-C, REVEL 0.06, ESM-1b 0.00
- P45A (p.Pro45Ala), ESP rs370236932, ExAC rs370236932, TOPMed rs370236932, gnomAD rs370236932, REVEL 0.02, ESM-1b 0.00
- P45L (p.Pro45Leu), cosmic curated COSV58019, ESP rs373966776, ExAC rs373966776, TOPMed rs373966776, REVEL 0.04, ESM-1b 0.00, Uncertain significance, not specified
- P45Q (p.Pro45Gln), ESP rs373966776, ExAC rs373966776, TOPMed rs373966776, gnomAD rs373966776, ESM-1b 0.00, AlphaMissense 0.09, Uncertain significance
- P45S (p.Pro45Ser), cosmic curated COSV10465, ESM-1b 0.00, AlphaMissense 0.08
- P45T (p.Pro45Thr), ESP rs370236932, ExAC rs370236932, TOPMed rs370236932, gnomAD rs370236932, REVEL 0.04, ESM-1b 0.00
- P45P (p.Pro45Pro), gnomAD 1-155717095-G-C, CADD 1.79
- R46K (p.Arg46Lys), TOPMed rs936896915, gnomAD rs936896915, REVEL 0.13, ESM-1b 0.00
- R46G (p.Arg46Gly), gnomAD 1-155717096-A-G, REVEL 0.27, ESM-1b 0.00
- A47G (p.Ala47Gly), TOPMed rs1657430479, ESM-1b 0.00, AlphaMissense 0.10
- I48V (p.Ile48Val), gnomAD rs1185138220, REVEL 0.02, ESM-1b 0.00
- S49F (p.Ser49Phe), gnomAD rs1385496823, REVEL 0.04, ESM-1b 0.00
- S49S (p.Ser49Ser), rs776731938, gnomAD 1-155717107-C-T, CADD 5.42
- R50C (p.Arg50Cys), ExAC rs377474444, TOPMed rs377474444, gnomAD rs377474444, REVEL 0.04, ESM-1b 0.00
- R50H (p.Arg50His), rs149919712, cosmic curated COSV58023, ESP rs149919712, ExAC rs149919712, REVEL 0.08, ESM-1b 0.00, Uncertain significance, not specified
- T51I (p.Thr51Ile), gnomAD rs1319635829, REVEL 0.20, ESM-1b 0.00
- T51P (p.Thr51Pro), ExAC rs773565559, TOPMed rs773565559, gnomAD rs773565559, REVEL 0.43, ESM-1b 0.00
- T51A (p.Thr51Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- T51T (p.Thr51Thr), rs375876872, gnomAD 1-155717113-C-T, CADD 6.49
- N52N (p.Asn52Asn), gnomAD 1-155717116-T-C, CADD 7.87
- N52K (p.Asn52Lys), gnomAD 1-155717116-T-G, REVEL 0.02, ESM-1b 0.00
- E53K (p.Glu53Lys), cosmic curated COSV58019, REVEL 0.13, ESM-1b 0.00
- E53G (p.Glu53Gly), gnomAD 1-155717118-A-G, REVEL 0.17, ESM-1b 0.00
- E53E (p.Glu53Glu), gnomAD 1-155717119-G-A, CADD 7.29
- N54T (p.Asn54Thr), gnomAD 1-155717121-A-C, REVEL 0.03, ESM-1b 0.00
- D55E (p.Asp55Glu), TOPMed rs1657433338, ESM-1b 0.00, AlphaMissense 0.35
- D55G (p.Asp55Gly), Ensembl rs1571508083, REVEL 0.17, ESM-1b 0.00
- D55N (p.Asp55Asn), NCI-TCGA Cosmic COSV5802, cosmic curated COSV58020, ESM-1b 0.00, AlphaMissense 0.11, Variant assessed as somatic; moderate impact.
- P56A (p.Pro56Ala), Ensembl rs1657433715, REVEL 0.26, ESM-1b 0.00
- P56L (p.Pro56Leu), TOPMed rs201385663, gnomAD rs201385663, REVEL 0.48, ESM-1b 0.00, Uncertain significance, not specified
- P56R (p.Pro56Arg), gnomAD 1-155717127-C-G, REVEL 0.56, ESM-1b 0.57
- P56P (p.Pro56Pro), rs148684040, gnomAD 1-155717128-G-A, CADD 22.60
- A57D (p.Ala57Asp), cosmic curated COSV58022, ESM-1b 0.00, AlphaMissense 0.36
- A57T (p.Ala57Thr), gnomAD 1-155721517-G-A, REVEL 0.21, ESM-1b 0.00
- K58N (p.Lys58Asn), ExAC rs774733542, gnomAD rs774733542, REVEL 0.03, ESM-1b 0.00
- H59R (p.His59Arg), TOPMed rs1321458708, gnomAD rs1321458708, REVEL 0.36, ESM-1b 0.00
- H59Y (p.His59Tyr), rs759970366, NCI-TCGA Cosmic COSV1005, cosmic curated COSV10054, ExAC rs759970366, REVEL 0.30, ESM-1b 0.00, Variant assessed as somatic; moderate impact.
- H59H (p.His59His), gnomAD 1-155721525-T-C, CADD 7.08
- G60C (p.Gly60Cys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G60R (p.Gly60Arg), TOPMed rs1357449951, gnomAD rs1357449951, REVEL 0.06, ESM-1b 0.17
- D61E (p.Asp61Glu), Ensembl rs1658017533, ESM-1b 0.00, AlphaMissense 0.06
- D61N (p.Asp61Asn), ExAC rs767996923, gnomAD rs767996923, REVEL 0.12, ESM-1b 0.00
- D61V (p.Asp61Val), cosmic curated COSV10968, ExAC rs775853011, gnomAD rs775853011, REVEL 0.04, ESM-1b 0.00
- D61Y (p.Asp61Tyr), cosmic curated COSV58021, REVEL 0.16, ESM-1b 0.69
- D61A (p.Asp61Ala), gnomAD 1-155721530-A-C, REVEL 0.03, ESM-1b 0.00
- Q62* (p.Gln62Ter), NCI-TCGA Cosmic COSV5802, cosmic curated COSV58022, Variant assessed as somatic; high impact.
- Q62H (p.Gln62His), cosmic curated COSV58020, ESM-1b 0.00, AlphaMissense 0.10
- Q62P (p.Gln62Pro), gnomAD 1-155721533-A-C, REVEL 0.10, ESM-1b 1.00
- H63Y (p.His63Tyr), TOPMed rs1411226963, gnomAD rs1411226963, REVEL 0.28, ESM-1b 1.00
- H63H (p.His63His), rs760288202, gnomAD 1-155721537-C-T, CADD 3.28
- H63Q (p.His63Gln), gnomAD 1-155721537-C-G, REVEL 0.12, ESM-1b 1.00
- E64K (p.Glu64Lys), TOPMed rs1196459888, gnomAD rs1196459888, REVEL 0.06, ESM-1b 1.00
- E64V (p.Glu64Val), TOPMed rs1443574435, gnomAD rs1443574435, REVEL 0.07, ESM-1b 1.00
- G65D (p.Gly65Asp), ExAC rs763570884, gnomAD rs763570884, REVEL 0.32, ESM-1b 1.00
- G65R (p.Gly65Arg), gnomAD rs879023821, REVEL 0.28, ESM-1b 1.00
- G65S (p.Gly65Ser), gnomAD rs879023821, REVEL 0.18, ESM-1b 1.00
- G65V (p.Gly65Val), ExAC rs763570884, gnomAD rs763570884, REVEL 0.34, ESM-1b 1.00
- Q66R (p.Gln66Arg), TOPMed rs1256281261, gnomAD rs1256281261, REVEL 0.04, ESM-1b 1.00, Uncertain significance, not specified
- Q66* (p.Gln66Ter), gnomAD 1-155721544-C-T, CADD 36.00
- Q66P (p.Gln66Pro), gnomAD 1-155721545-A-C, REVEL 0.25, ESM-1b 1.00
- H67Y (p.His67Tyr), TOPMed rs1658020869, ESM-1b 0.00, AlphaMissense 0.06
- Y68C (p.Tyr68Cys), gnomAD rs1437998180, REVEL 0.63, ESM-1b 1.00
- N69S (p.Asn69Ser), rs753527370, ClinGen CA1149211, ClinVar RCV004262578, ExAC rs753527370, REVEL 0.08, ESM-1b 0.00, Likely benign, not specified
- N69del (p.Asn69del), rs1658021470, gnomAD 1-155721550-TACA-, CADD 20.40
- N69H (p.Asn69His), gnomAD 1-155721553-A-C, REVEL 0.07, ESM-1b 0.00
- N69N (p.Asn69Asn), gnomAD 1-155721555-C-T, CADD 14.30
Public DAP3 analysis runs
- DAP3 analysis run — DAP3 (651 variants) — completed 2026-10-10